Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

L Velíšek, J Velíšková - Pharmacology & therapeutics, 2020 - Elsevier
Infantile spasms (IS or epileptic spasms during infancy) were first described by Dr. William
James West (aka West syndrome) in his own son in 1841. While rare by definition (occurring …

Treatment of infantile spasms: why do we know so little?

N Specchio, N Pietrafusa, A Ferretti… - Expert review of …, 2020 - Taylor & Francis
Introduction Infantile spasm (IS) is an epileptic syndrome with typical onset within the first 2
years of life. This condition might be caused by several etiologies. IS is associated with …

Enantioselective Synthesis of Chiral 1, 5-Benzodiazepin-2-ones by Pd-Catalyzed Asymmetric Hydrogenation and Reductive Amination

Q Guo, C **e, G Zi, G Hou - Organic Letters, 2024 - ACS Publications
The enantioselective synthesis of chiral 4-substituted 4, 5-dihydro-1 H-[1, 5] benzodiazepin-
2 (3 H)-ones via asymmetric hydrogenation catalyzed by the Pd/f-spiroPhos complex in the …

[HTML][HTML] Optimized treatment for infantile spasms: vigabatrin versus prednisolone versus combination therapy

J Hahn, G Park, HC Kang, JS Lee, HD Kim… - Journal of Clinical …, 2019 - mdpi.com
Hormone therapies and vigabatrin are first-line agents in infantile spasms, but more than
one-third of patients fail to respond to these treatments. This was a retrospective study of …

Effectiveness of ACTH in patients with infantile spasms

J Paprocka, J Malkiewicz, V Palazzo-Michalska… - Brain sciences, 2022 - mdpi.com
(1) Background: West syndrome is a severe, refractory, epileptic syndrome that usually
appears in infancy or early childhood. ACTH is one of the more effective drugs for treating …

The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study

T Kamaşak, E Serdaroğlu, Ö Yılmaz, BA Kılıç… - Epilepsy Research, 2022 - Elsevier
Objective To evaluate the effectiveness and tolerability of clobazam therapy in the pediatric
population in terms of seizure semiology, epileptic syndromes, and etiological subgroups …

CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up

D Türkdoğan, G Öztürk - Acta Neurologica Belgica, 2022 - Springer
Clobazam (CLB) is an effective anticonvulsant used as an adjunctive treatment for several
seizures and epilepsy syndromes. Data are limited on efficacy and safety of CLB as add-on …

氯巴占附加治疗儿童难治性癫痫的有效性和安全性单组率的 Meta 分析

涂彩霞, 任丹阳, 沈建玲, **云巍, 杨琰茗… - ** …, 2024 - journal.china-pharmacy.com
目的探讨氯巴占附加治疗儿童难治性癫痫的有效性和安全性, 为临床安全, 合理用药提供参考.
方法计算机检索PubMed, The Cochrane Library, Embase, **知网, 维普网 …

婴儿癫痫性痉挛综合征诊治进展

郑璐, 杨婷, 陈超阳, 魏然, 张玄龄, 马医杰, 周颖 - 罕见病研究, 2024 - jrd.chard.org.cn
婴儿癫痫性痉挛综合征(IESS) 是最**几年提出的一个新概念, 是一种独特的,
具有年龄特异性的难治性癫痫综合征. **年来, 随着分子生物学, 神经免疫学的发展以及抗癫痫 …

Factors in first-time adrenocorticotropic hormone therapy and their influence on spasm control time in infantile spasms: a Cox proportional-hazards regression model …

L Wan, G Yang, LP Zou, J Wang, XY Shi… - … Dang dai er ke za zhi …, 2019 - europepmc.org
OBJECTIVE: To investigate the factors in first-time adrenocorticotropic hormone (ACTH)
therapy and their influence on spasm control time in infants with infantile spasms …